PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.23%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-7.26%
Negative gross profit growth while AVGO is at 1.32%. Joel Greenblatt would examine cost competitiveness or demand decline.
-9.56%
Negative EBIT growth while AVGO is at 2.94%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-11.12%
Negative operating income growth while AVGO is at 2.94%. Joel Greenblatt would press for urgent turnaround measures.
-12.95%
Negative net income growth while AVGO stands at 12.35%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-12.96%
Negative EPS growth while AVGO is at 11.11%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-13.15%
Negative diluted EPS growth while AVGO is at 14.29%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.11%
Share reduction more than 1.5x AVGO's 1.70%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
No Data
No Data available this quarter, please select a different quarter.
0.07%
Dividend growth under 50% of AVGO's 6.27%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
-43.19%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-83.44%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
85.25%
10Y revenue/share CAGR under 50% of AVGO's 810.87%. Michael Burry would suspect a lasting competitive disadvantage.
25.26%
5Y revenue/share CAGR under 50% of AVGO's 64.15%. Michael Burry would suspect a significant competitive gap or product weakness.
35.02%
3Y revenue/share CAGR at 75-90% of AVGO's 44.90%. Bill Ackman would expect new product strategies to close the gap.
293.27%
10Y OCF/share CAGR under 50% of AVGO's 1183.92%. Michael Burry would worry about a persistent underperformance in cash creation.
13.06%
Below 50% of AVGO's 134.94%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
39.92%
3Y OCF/share CAGR at 50-75% of AVGO's 65.50%. Martin Whitman would suspect weaker recent execution or product competitiveness.
475.86%
Below 50% of AVGO's 1676.85%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
35.51%
Positive 5Y CAGR while AVGO is negative. John Neff might view this as a strong mid-term relative advantage.
49.34%
Below 50% of AVGO's 833.36%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
69.87%
Below 50% of AVGO's 444.81%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
55.24%
Positive 5Y equity/share CAGR while AVGO is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
102.31%
Positive short-term equity growth while AVGO is negative. John Neff sees a strong advantage in near-term net worth buildup.
491.84%
Below 50% of AVGO's 2598.77%. Michael Burry might see weaker long-term distribution growth, raising questions about the firm's capital allocation.
99.55%
5Y dividend/share CAGR at 50-75% of AVGO's 150.22%. Martin Whitman might see a lagging policy in mid-term shareholder returns.
37.31%
3Y dividend/share CAGR 1.25-1.5x AVGO's 33.66%. Bruce Berkowitz checks if the company's short-term profits or payout policy justify these higher hikes.
-0.95%
Firm’s AR is declining while AVGO shows 9.33%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
19.26%
We show growth while AVGO is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
7.40%
Positive asset growth while AVGO is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
4.45%
BV/share growth above 1.5x AVGO's 0.93%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
11.53%
We have some new debt while AVGO reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
4.84%
We increase R&D while AVGO cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
10.49%
We expand SG&A while AVGO cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.